Published in Medicine (Baltimore) on July 01, 1976
Ocular manifestations of systemic lupus erythematosus: a review of the literature. Autoimmune Dis (2012) 1.61
Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A (1978) 1.57
Remittent painful ophthalmoplegia: the Tolosa-Hunt syndrome? A report of seven cases and review of the literature. J Neurol Neurosurg Psychiatry (1979) 1.20
Cerebellar ataxia in systemic lupus erythematosus: three case reports. Ann Rheum Dis (1988) 1.12
Chorea in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis (1988) 1.10
Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus. J Rheumatol (2008) 1.07
An unusual case of systemic lupus erythematosus with isolated hypoglossal nerve palsy, fulminant acute pneumonitis, and pulmonary amyloidosis. Ann Rheum Dis (1989) 1.07
Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis (1989) 1.03
Cerebellum and brainstem vasculopathy in systemic lupus erythematosus: two clinico-pathological cases. Ann Rheum Dis (1994) 1.03
Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study. Arthritis Rheum (2008) 1.01
Hippocampal atrophy in systemic lupus erythematosus. Ann Rheum Dis (2006) 1.00
Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis (1989) 1.00
Stroke as an early manifestation of systemic lupus erythematosus. J Neurol Neurosurg Psychiatry (1982) 0.98
The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus. J Biomed Biotechnol (2011) 0.97
Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus. Ann Rheum Dis (1990) 0.96
Antibodies to protein P in systemic lupus erythematosus. Ann Rheum Dis (1992) 0.90
Cortical thickness and subcortical gray matter reductions in neuropsychiatric systemic lupus erythematosus. PLoS One (2010) 0.89
Haematological manifestations of lupus. Lupus Sci Med (2015) 0.89
Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV). Ann Rheum Dis (2007) 0.88
Cerebral systemic lupus erythematosus presenting with catatonia. Postgrad Med J (1985) 0.85
Acute transverse myelopathy complicating systemic lupus erythematosus. Ann Rheum Dis (1989) 0.84
Prevalence of depression and depressive symptoms in patients with systemic lupus erythematosus: Iranian experience. Rheumatol Int (2011) 0.83
Peripheral neuropathies due to systemic lupus erythematosus in China. Medicine (Baltimore) (2015) 0.83
Brain scan diagnosis of central nervous system involvement in systemic lupus erythematosus. Ann Rheum Dis (1978) 0.82
Recurrent lower motor neuron type facial palsy: an unusual manifestation of SLE. BMJ Case Rep (2011) 0.82
Tetraplegia as a presenting feature of systemic lupus erythematosus complicated by pulmonary hypertension. Ann Rheum Dis (1985) 0.82
Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus. Arthritis Res Ther (2004) 0.82
Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement. Arthritis Res Ther (2004) 0.82
Seroprevalence and specificity of NMO-IgG (anti-aquaporin 4 antibodies) in patients with neuropsychiatric systemic lupus erythematosus. Rheumatol Int (2011) 0.81
Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus. PLoS One (2015) 0.81
Primary Sjögren's syndrome preceding the presentation of systemic lupus erythematosus as a benign intracranial hypertension syndrome. Ann Rheum Dis (1992) 0.80
Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort. Arthritis Care Res (Hoboken) (2012) 0.80
Cerebral occlusive vasculopathy in systemic lupus erythematosus and speculation on the part played by complement. Ann Rheum Dis (1992) 0.80
Neuropsychiatric systemic lupus erythematosus in elderly people: a case series. J Neurol Neurosurg Psychiatry (1992) 0.79
Brain-reactive autoantibody levels in the sera of ageing autoimmune mice. Clin Exp Immunol (1987) 0.79
Systemic lupus erythematosus patients with central nervous system involvement show autoantibodies to a 50-kD neuronal membrane protein. J Exp Med (1992) 0.79
Ocular findings in systemic lupus erythematosus. Saudi J Ophthalmol (2016) 0.78
The pathogenesis of neuropsychiatric lupus. Can Med Assoc J (1983) 0.78
Psychiatric disorders in patients with systemic lupus erythematosus: association of anxiety disorder with shorter disease duration. Rheumatol Int (2010) 0.77
Attributing psychopathology to systemic lupus erythematosus: some methodological considerations. Ann Rheum Dis (1992) 0.77
Central nervous system systemic lupus erythematosus mimicking progressive multifocal leucoencephalopathy. Ann Rheum Dis (1992) 0.77
Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE). Postgrad Med J (1993) 0.76
Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case-control study from a single center. Rheumatol Int (2010) 0.76
Thrombocytopenia in Systemic Lupus Erythematosus: Clinical Manifestations, Treatment, and Prognosis in 230 Patients. Medicine (Baltimore) (2016) 0.75
High prevalence of myositis in a southeastern United States pediatric systemic lupus erythematosus cohort. Pediatr Rheumatol Online J (2011) 0.75
New approaches to treating systemic lupus erythematosus. West J Med (1987) 0.75
Cerebral systemic lupus erythematosus. Arch Dis Child (1988) 0.75
Ptosis in systemic lupus erythematosus. Postgrad Med J (1982) 0.75
Myelopathy in neonatal and infantile lupus erythematosus. J Neurol Neurosurg Psychiatry (1987) 0.75
Systemic lupus erythematosus presenting as morbid jealousy. Postgrad Med J (1980) 0.75
Neuropsychiatric Symptoms as The First Manifestation of Juvenile Systemic Lupus Erythematosus: A Complicated Case with Klinefelter's Syndrome. Iran J Child Neurol (2014) 0.75
Cerebral systemic lupus erythematosus: a case report and evaluation of diagnostic tests. J Neurol Neurosurg Psychiatry (1980) 0.75
A case of systemic lupus erythematosus presenting as hypoglycemia due to anti-insulin receptor antibodies. Rheumatol Int (2008) 0.75
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum (1998) 12.36
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum (1990) 8.23
Antibodies to type II collagen in relapsing polychondritis. N Engl J Med (1978) 2.65
Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome. Arthritis Rheum (1986) 2.39
Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest (1996) 2.39
Incomplete Reiter's syndrome: discriminating features and HL-A W27 in diagnosis. Ann Intern Med (1976) 2.34
TCA-based blue peel: a standardized procedure with depth control. Dermatol Surg (1999) 2.15
PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J Clin Invest (1999) 2.14
Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) (1985) 2.01
Association of labial salivary gland histopathology with clinical and serologic features of connective tissue diseases. Arthritis Rheum (1990) 1.99
Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Arthritis Rheum (1981) 1.97
Epidemic viral hepatitis, type B, in hospital personnel. Am J Med (1974) 1.87
Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum (2001) 1.87
Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford) (2006) 1.77
Evidence that autoimmunity in man is a Mendelian dominant trait. Am J Hum Genet (1986) 1.74
The pseudothrombophlebitis syndrome. Medicine (Baltimore) (1977) 1.71
Studies in familial systemic lupus erythematosus. Medicine (Baltimore) (1976) 1.70
Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med (1983) 1.68
An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis. Rheumatology (Oxford) (2007) 1.63
Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum (1999) 1.58
Severe retinal vaso-occlusive disease in systemic lupus erythematous. Arch Ophthalmol (1986) 1.56
Racial differences in the frequencies of scleroderma-related autoantibodies. Arthritis Rheum (1992) 1.53
Genetic factors predisposing to autoimmune diseases. Autoimmune hemolytic anemia, chronic thrombocytopenic purpura, and systemic lupus erythematosus. Am J Med (1982) 1.51
Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science (1986) 1.50
Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum (1988) 1.47
Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med (1985) 1.45
Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Arthritis Rheum (1999) 1.45
Adult onset polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature. Semin Arthritis Rheum (1986) 1.43
The 'CREST' syndrome. Comparison with systemic sclerosis (scleroderma). Arch Intern Med (1979) 1.42
Intravenous pulsed steroids in rheumatoid arthritis: a comparative dose study. J Rheumatol (1990) 1.42
Complement component C4A and C4B levels in systemic lupus erythematosus: quantitation in relation to C4 null status and disease activity. J Rheumatol (1993) 1.42
The arthropathy of Behçet's disease. Johns Hopkins Med J (1975) 1.41
Autoantibodies and rheumatic disorders in a neurology inpatient population: a prospective study. Am J Med (1991) 1.40
Acute abdominal complications of systemic lupus erythematosus and polyarteritis nodosa. Am J Med (1982) 1.34
Neurologic complications of primary Sjögren's syndrome. Medicine (Baltimore) (1982) 1.34
Incomplete Reiter's syndrome: clinical comparisons with classical triad. Ann Rheum Dis (1979) 1.34
Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans. Am J Med (1986) 1.31
Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature. Medicine (Baltimore) (1984) 1.30
Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med (1985) 1.28
Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. Arthritis Rheum (1982) 1.27
Incidence of lung cancer in systemic sclerosis. J Rheumatol (1985) 1.22
Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest (1992) 1.21
Sjögren syndrome: central nervous system manifestations. Neurology (1981) 1.15
Delayed hypersensitivity in systemic lupus erythematosus. Ann Rheum Dis (1968) 1.15
HLA haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a Native American population with a high prevalence of scleroderma (systemic sclerosis). Tissue Antigens (1999) 1.14
Revised criteria for the classification of rheumatoid arthritis. Bull Rheum Dis (1989) 1.14
Skeletal manifestations of polymyalgia rheumatica. JAMA (1978) 1.13
HL-A 27 in Reiter's syndrome and psoriatic arthritis: a genetic factor in disease susceptibility and expression. J Rheumatol (1984) 1.13
Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med (1990) 1.12
HLA-DR characterization of a Chippewa Indian subpopulation with high prevalence of rheumatoid arthritis. Hum Immunol (1981) 1.11
Primary Sjögren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds. Ann Intern Med (1984) 1.11
Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts. J Immunol (2001) 1.11
Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses. J Immunol (1991) 1.11
Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma). J Clin Invest (1992) 1.11
The genetics of lupus. Curr Opin Rheumatol (1998) 1.10
Strength training increases regional bone mineral density and bone remodeling in middle-aged and older men. J Appl Physiol (1985) (1993) 1.10
Homozygous C2 deficiency, lupus erythematosus, and anti-Ro (SSA) antibodies. Arthritis Rheum (1983) 1.08
Alcoholism associated ischemic necrosis of the femoral head. Early diagnosis and treatment. Clin Orthop Relat Res (1978) 1.08
The coexistence of rheumatoid arthritis with Reiter's syndrome and/or ankylosing spondylitis: a model of dual HLA-associated disease susceptibility and expression. J Rheumatol (1981) 1.08
Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum (1996) 1.08
Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases. J Immunol (1999) 1.07
Optic neuropathy in systemic lupus erythematosus. Arch Ophthalmol (1986) 1.06
BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians. Ann Rheum Dis (2009) 1.06
Multiplicity of antibodies in myositis sera. Arthritis Rheum (1984) 1.05
Primary Sjögren's syndrome in men. Clinical, serologic, and immunogenetic features. Am J Med (1986) 1.05
Null alleles of the fourth component of complement and HLA haplotypes in familial systemic lupus erythematosus. Immunogenetics (1985) 1.04
Family studies in HLA-B27 associated arthritis. Medicine (Baltimore) (1978) 1.04
Sjögren's syndrome. Influence of multiple HLA-D region alloantigens on clinical and serologic expression. Arthritis Rheum (1984) 1.04
Connective tissue disease in the elderly. Clin Rheum Dis (1986) 1.03
Palmar fasciitis and arthritis with malignant neoplasms: a paraneoplastic syndrome. Semin Arthritis Rheum (1986) 1.03
Antibodies against Ku protein in sera from patients with autoimmune diseases. Clin Exp Immunol (1989) 1.03
Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis. Ann Rheum Dis (2010) 1.02
Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome. J Rheumatol (1982) 1.02
Destructive monarthritis and granulomatous synovitis as the presenting manifestations of Crohn's disease. Johns Hopkins Med J (1975) 1.02
Arsenic intoxication from well water in the United States. N Engl J Med (1973) 1.01
A zinc finger protein that represses transcription of the human MHC class II gene, DPA. J Immunol (1996) 1.01
Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku. Am J Med (1992) 1.01
Hypothyroidism presenting as a polymyositis-like syndrome. Report of two cases. Arthritis Rheum (1977) 1.01
Epstein-Barr virus (herpes-type virus) antibodies in connective tissue diseases. Arch Intern Med (1972) 1.01
Rheumatoid arthritis in a Chippewa Band. I. Pilot screening study of disease prevalence. Arthritis Rheum (1981) 1.01
Seronegative spondylarthropathies. Bull Rheum Dis (1987) 1.00
Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis. Medicine (Baltimore) (1984) 1.00
The Jo-1 antibody system in myositis: relationships to clinical features and HLA. J Rheumatol (1982) 0.99
Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis. Am J Med (1984) 0.97
Familial occurrence of progressive systemic sclerosis and systemic lupus erythematosus. J Rheumatol (1984) 0.97
Cutaneous vasculitis in adult polymyositis/dermatomyositis. J Rheumatol (1983) 0.97